4.6 Review

NAD+ and sirtuins in aging and disease

Journal

TRENDS IN CELL BIOLOGY
Volume 24, Issue 8, Pages 464-471

Publisher

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tcb.2014.04.002

Keywords

NAD(+); sirtuins; poly-ADP-ribose polymerases; nicotinamide phosphoribosyltransferase; nicotinamide mononucleotide; nicotinamide riboside

Categories

Funding

  1. National Institute on Aging [AG024150, AG037457]
  2. Glenn Foundation for Medical Research
  3. National Institutes of Health

Ask authors/readers for more resources

Nicotinamide adenine dinucleotide (NAD(+)) is a classical coenzyme mediating many redox reactions. NAD(+) also plays an important role in the regulation of NAD(+)-consuming enzymes, including sirtuins, poly-ADP-ribose polymerases (PARPs), and CD38/157 ectoenzymes. NAD(+) biosynthesis, particularly mediated by nicotinamide phosphoribosyltransferase (NAMPT), and SIRT1 function together to regulate metabolism and circadian rhythm. NAD(+) levels decline during the aging process and may be an Achilles' heel, causing defects in nuclear and mitochondrial functions and resulting in many age-associated pathologies. Restoring NAD(+) by supplementing NAD(+) intermediates can dramatically ameliorate these age-associated functional defects, counteracting many diseases of aging, including neurodegenerative diseases. Thus, the combination of sirtuin activation and NAD(+) intermediate supplementation may be an effective antiaging intervention, providing hope to aging societies worldwide.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available